RESTRICTED STOCK (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options And Restricted Stock
Non-cash compensation expense	$ 529,795	$ 574,024	$ 323,463
Outstanding restricted stock grants	201,655
Weighted average grant date value	$ 10.66
Shares of non-vested restricted stock	201,655
Total unrecognized compensation expense	$ 902,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	54,510
Yearly [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	147,145